Catalyst Wire Dossier Catalyst Wire Dossier

A 623

· Anthera Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A 623, covering 2014-03-04 to 2014-03-04. Get the full timeline:

Most recent: Clinical Trial Update: PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus [Phase 2]

See pricing